Cullgen (shanghai),inc
Clinical trials sponsored by Cullgen (shanghai),inc, explained in plain language.
-
New pill targets rare gene faults in Hard-to-Treat cancers
Disease control Recruiting nowThis study tests an experimental drug called CG001419 in adults with advanced solid tumors that have certain NTRK gene changes. The trial has two parts: first, finding a safe dose and checking for side effects; second, seeing if the drug can shrink tumors. About 42 people will ta…
Phase: PHASE1, PHASE2 • Sponsor: Cullgen (Shanghai),Inc • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New hope for tough blood cancers? early trial of CG009301 begins
Disease control Recruiting nowThis early-phase trial is testing a new drug called CG009301 in adults with blood cancers like leukemia that have returned or not responded to standard treatments. The main goals are to find a safe dose and see if the drug can help. About 45 participants will receive the drug by …
Phase: PHASE1 • Sponsor: Cullgen (Shanghai),Inc • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC